| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA photolyase activity | 3.64e-05 | 2 | 121 | 2 | GO:0003913 | |
| GeneOntologyMolecularFunction | DNA (6-4) photolyase activity | 3.64e-05 | 2 | 121 | 2 | GO:0003914 | |
| GeneOntologyMolecularFunction | deoxyribodipyrimidine photo-lyase activity | 3.64e-05 | 2 | 121 | 2 | GO:0003904 | |
| GeneOntologyMolecularFunction | blue light photoreceptor activity | 3.64e-05 | 2 | 121 | 2 | GO:0009882 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 5.00e-05 | 66 | 121 | 5 | GO:0005080 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.66e-04 | 18 | 121 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | neuregulin binding | 5.38e-04 | 6 | 121 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 6.37e-04 | 28 | 121 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.37e-04 | 28 | 121 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 1.23e-03 | 35 | 121 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 1.26e-03 | 431 | 121 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | steroid binding | 1.30e-03 | 133 | 121 | 5 | GO:0005496 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 OR4N4 OR6Q1 OR2G3 CASR CD300C TAS2R3 OR6B3 OR10G3 PTPRO GPR149 OR13A1 OR10W1 SCN7A RXFP1 OR6C6 OR6B2 ALK | 1.31e-03 | 1353 | 121 | 18 | GO:0004888 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.45e-03 | 37 | 121 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | U3 snoRNA binding | 1.93e-03 | 11 | 121 | 2 | GO:0034511 | |
| GeneOntologyMolecularFunction | transporter activity | NPC1 CACNA2D2 CALHM1 SLC35C1 PIEZO1 CALHM3 SLC22A18 SLC12A9 ABCA5 SLC17A1 CLDN17 SCN7A OSBPL5 TMC8 TMCO1 MFSD3 SLC22A31 | 1.97e-03 | 1289 | 121 | 17 | GO:0005215 |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 1.81e-06 | 5 | 118 | 3 | GO:0006711 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 1.81e-06 | 5 | 118 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 3.61e-06 | 6 | 118 | 3 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 3.61e-06 | 6 | 118 | 3 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 3.61e-06 | 6 | 118 | 3 | GO:0051552 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 2.13e-05 | 10 | 118 | 3 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 2.13e-05 | 10 | 118 | 3 | GO:0009804 | |
| GeneOntologyBiologicalProcess | blue light signaling pathway | 3.25e-05 | 2 | 118 | 2 | GO:0009785 | |
| GeneOntologyBiologicalProcess | cellular response to blue light | 3.25e-05 | 2 | 118 | 2 | GO:0071483 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 3.87e-05 | 12 | 118 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 5.01e-05 | 13 | 118 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR4N4 OR6Q1 PIEZO1 OR2G3 CASR TAS2R3 OR6B3 OR10G3 OR13A1 OR10W1 STRC OR6C6 OR6B2 STRCP1 | 6.61e-05 | 722 | 118 | 14 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR4N4 CALHM1 OR6Q1 OR2G3 CALHM3 TAS2R3 OR6B3 OR10G3 OR13A1 OR10W1 OR6C6 OR6B2 | 7.13e-05 | 547 | 118 | 12 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR4N4 OR6Q1 OR2G3 TAS2R3 OR6B3 OR10G3 OR13A1 OR10W1 STRC OR6C6 OR6B2 STRCP1 | 1.28e-04 | 582 | 118 | 12 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR4N4 OR6Q1 OR2G3 CASR TAS2R3 OR6B3 OR10G3 OR13A1 OR10W1 OR6C6 OR6B2 | 2.12e-04 | 524 | 118 | 11 | GO:0009593 |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 2.25e-04 | 21 | 118 | 3 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 2.25e-04 | 21 | 118 | 3 | GO:0042447 | |
| GeneOntologyBiologicalProcess | negative regulation of corticosteroid hormone secretion | 3.21e-04 | 5 | 118 | 2 | GO:2000847 | |
| GeneOntologyBiologicalProcess | negative regulation of steroid hormone secretion | 3.21e-04 | 5 | 118 | 2 | GO:2000832 | |
| GeneOntologyBiologicalProcess | negative regulation of glucocorticoid secretion | 3.21e-04 | 5 | 118 | 2 | GO:2000850 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 4.31e-04 | 26 | 118 | 3 | GO:0019585 | |
| GeneOntologyBiologicalProcess | auditory receptor cell stereocilium organization | 4.31e-04 | 26 | 118 | 3 | GO:0060088 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 4.31e-04 | 26 | 118 | 3 | GO:0006063 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR4N4 OR6Q1 OR2G3 TAS2R3 OR6B3 OR10G3 OR13A1 OR10W1 OR6C6 OR6B2 | 4.76e-04 | 485 | 118 | 10 | GO:0050907 |
| GeneOntologyBiologicalProcess | response to blue light | 4.80e-04 | 6 | 118 | 2 | GO:0009637 | |
| GeneOntologyBiologicalProcess | negative regulation of glucocorticoid receptor signaling pathway | 4.80e-04 | 6 | 118 | 2 | GO:2000323 | |
| GeneOntologyCellularComponent | hemidesmosome | 3.02e-05 | 11 | 121 | 3 | GO:0030056 | |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 6.57e-05 | 14 | 121 | 3 | GO:0097732 | |
| GeneOntologyCellularComponent | kinocilium | 6.57e-05 | 14 | 121 | 3 | GO:0060091 | |
| GeneOntologyCellularComponent | dynein complex | 2.70e-04 | 54 | 121 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.96e-04 | 25 | 121 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | vesicle tethering complex | 8.11e-04 | 72 | 121 | 4 | GO:0099023 | |
| Domain | DNA_photolyase | 3.76e-05 | 2 | 115 | 2 | PF00875 | |
| Domain | DNA_photolyase_N | 3.76e-05 | 2 | 115 | 2 | IPR006050 | |
| Domain | FAD_binding_7 | 3.76e-05 | 2 | 115 | 2 | PF03441 | |
| Domain | Cryptochr/Photolyase_FAD-bd | 3.76e-05 | 2 | 115 | 2 | IPR005101 | |
| Domain | PHR_CRY_ALPHA_BETA | 3.76e-05 | 2 | 115 | 2 | PS51645 | |
| Domain | Dynein_HC_stalk | 7.88e-05 | 14 | 115 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.88e-05 | 14 | 115 | 3 | IPR013602 | |
| Domain | DHC_N2 | 7.88e-05 | 14 | 115 | 3 | PF08393 | |
| Domain | MT | 7.88e-05 | 14 | 115 | 3 | PF12777 | |
| Domain | - | 9.31e-05 | 74 | 115 | 5 | 3.40.50.410 | |
| Domain | DHC_fam | 9.80e-05 | 15 | 115 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 9.80e-05 | 15 | 115 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 9.80e-05 | 15 | 115 | 3 | PF03028 | |
| Domain | UDPGT | 2.79e-04 | 21 | 115 | 3 | PF00201 | |
| Domain | UDPGT | 2.79e-04 | 21 | 115 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 2.79e-04 | 21 | 115 | 3 | IPR002213 | |
| Domain | VWF_A | 3.66e-04 | 99 | 115 | 5 | IPR002035 | |
| Domain | FAM26 | 5.55e-04 | 6 | 115 | 2 | IPR029569 | |
| Domain | Ca_hom_mod | 5.55e-04 | 6 | 115 | 2 | PF14798 | |
| Domain | Olfact_rcpt | 7.29e-04 | 393 | 115 | 9 | IPR000725 | |
| Domain | Clathrin | 7.74e-04 | 7 | 115 | 2 | PF00637 | |
| Domain | CHCR | 7.74e-04 | 7 | 115 | 2 | PS50236 | |
| Domain | Clathrin_H-chain/VPS_repeat | 1.03e-03 | 8 | 115 | 2 | IPR000547 | |
| Domain | GPCR_Rhodpsn | OR4N4 OR6Q1 OR2G3 TAS2R3 OR6B3 OR10G3 GPR149 OR13A1 OR10W1 RXFP1 OR6C6 OR6B2 | 1.15e-03 | 692 | 115 | 12 | IPR000276 |
| Domain | VWFA | 1.65e-03 | 82 | 115 | 4 | PS50234 | |
| Domain | VWA | 1.80e-03 | 84 | 115 | 4 | SM00327 | |
| Domain | GPCR_Rhodpsn_7TM | OR4N4 OR6Q1 OR2G3 OR6B3 OR10G3 GPR149 OR13A1 OR10W1 RXFP1 OR6C6 OR6B2 | 2.83e-03 | 670 | 115 | 11 | IPR017452 |
| Domain | 7tm_1 | OR4N4 OR6Q1 OR2G3 OR6B3 OR10G3 GPR149 OR13A1 OR10W1 RXFP1 OR6C6 OR6B2 | 3.06e-03 | 677 | 115 | 11 | PF00001 |
| Domain | Dynein_heavy_chain_D4_dom | 3.26e-03 | 14 | 115 | 2 | IPR024317 | |
| Domain | AAA_8 | 3.26e-03 | 14 | 115 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 3.26e-03 | 14 | 115 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.26e-03 | 14 | 115 | 2 | PF07728 | |
| Domain | G_PROTEIN_RECEP_F1_1 | OR4N4 OR6Q1 OR2G3 OR6B3 OR10G3 GPR149 OR13A1 OR10W1 RXFP1 OR6C6 OR6B2 | 3.35e-03 | 685 | 115 | 11 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR4N4 OR6Q1 OR2G3 OR6B3 OR10G3 GPR149 OR13A1 OR10W1 RXFP1 OR6C6 OR6B2 | 3.58e-03 | 691 | 115 | 11 | PS50262 |
| Domain | Helicase_C | 4.33e-03 | 107 | 115 | 4 | PF00271 | |
| Domain | HELICc | 4.33e-03 | 107 | 115 | 4 | SM00490 | |
| Domain | Helicase_C | 4.47e-03 | 108 | 115 | 4 | IPR001650 | |
| Domain | MFS | 4.47e-03 | 108 | 115 | 4 | PS50850 | |
| Domain | HELICASE_CTER | 4.62e-03 | 109 | 115 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.62e-03 | 109 | 115 | 4 | PS51192 | |
| Domain | DEXDc | 4.62e-03 | 109 | 115 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.77e-03 | 110 | 115 | 4 | IPR014001 | |
| Domain | VWA | 4.97e-03 | 56 | 115 | 3 | PF00092 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | CACNA2D2 OR4N4 CALHM1 OR6Q1 OR2G3 CALHM3 TAS2R3 OR6B3 OR10G3 OR13A1 OR10W1 GPC2 STRC OR6C6 OR6B2 | 7.11e-06 | 636 | 87 | 15 | M41834 |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 2.71e-04 | 51 | 87 | 4 | M17726 | |
| Pathway | WP_ESTROGEN_METABOLISM | 3.21e-04 | 22 | 87 | 3 | MM15888 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.18e-04 | 24 | 87 | 3 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 4.73e-04 | 25 | 87 | 3 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 4.73e-04 | 25 | 87 | 3 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 4.73e-04 | 25 | 87 | 3 | M605 | |
| Pathway | WP_GLUCURONIDATION | 5.33e-04 | 26 | 87 | 3 | M39404 | |
| Pathway | BIOCARTA_CIRCADIAN_PATHWAY | 5.56e-04 | 6 | 87 | 2 | M22067 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_SALTY_TASTE | 5.56e-04 | 6 | 87 | 2 | M42526 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 6.65e-04 | 28 | 87 | 3 | M19580 | |
| Pathway | BIOCARTA_CIRCADIAN_PATHWAY | 7.75e-04 | 7 | 87 | 2 | MM1578 | |
| Pubmed | Phosphorylation of the cryptochrome 1 C-terminal tail regulates circadian period length. | 4.21e-08 | 3 | 122 | 3 | 24158435 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 2.54e-07 | 16 | 122 | 4 | 19414484 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 20565459 | ||
| Pubmed | Essential role of alpha 6 integrins in cortical and retinal lamination. | 8.36e-07 | 6 | 122 | 3 | 9742403 | |
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 32527940 | ||
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 1.46e-06 | 7 | 122 | 3 | 8467709 | |
| Pubmed | 1.46e-06 | 7 | 122 | 3 | 8464825 | ||
| Pubmed | 1.46e-06 | 7 | 122 | 3 | 27514509 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 DOCK3 EPPK1 PIEZO1 PIGG COMTD1 STK11IP ITGB4 SETD5 MCM3AP CSPG4 OSBPL5 NADK PRKDC GPC2 ULK2 | 1.70e-06 | 1105 | 122 | 16 | 35748872 |
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 20610558 | ||
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 18052087 | ||
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 17179145 | ||
| Pubmed | 3.48e-06 | 9 | 122 | 3 | 22511988 | ||
| Pubmed | 4.96e-06 | 10 | 122 | 3 | 23642732 | ||
| Pubmed | 4.96e-06 | 10 | 122 | 3 | 11465080 | ||
| Pubmed | 4.96e-06 | 10 | 122 | 3 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 4.96e-06 | 10 | 122 | 3 | 22558097 | |
| Pubmed | 6.81e-06 | 11 | 122 | 3 | 18695635 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 9.05e-06 | 12 | 122 | 3 | 20308471 | |
| Pubmed | 9.05e-06 | 12 | 122 | 3 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 9.05e-06 | 12 | 122 | 3 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.17e-05 | 13 | 122 | 3 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.17e-05 | 13 | 122 | 3 | 25246029 | |
| Pubmed | Delay in feedback repression by cryptochrome 1 is required for circadian clock function. | 1.22e-05 | 2 | 122 | 2 | 21236481 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20825493 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19211562 | ||
| Pubmed | Clock Regulation of Metabolites Reveals Coupling between Transcription and Metabolism. | 1.22e-05 | 2 | 122 | 2 | 28380384 | |
| Pubmed | Circadian oscillation of nucleotide excision repair in mammalian brain. | 1.22e-05 | 2 | 122 | 2 | 19164551 | |
| Pubmed | Circadian intraocular pressure rhythm is generated by clock genes. | 1.22e-05 | 2 | 122 | 2 | 16936122 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15731010 | ||
| Pubmed | Posttranslational regulation of CALHM1/3 channel: N-linked glycosylation and S-palmitoylation. | 1.22e-05 | 2 | 122 | 2 | 33788965 | |
| Pubmed | Characterization of photolyase/blue-light receptor homologs in mouse and human cells. | 1.22e-05 | 2 | 122 | 2 | 9801304 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21969027 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22464766 | ||
| Pubmed | Autonomic and cardiovascular responses to scent stimulation are altered in cry KO mice. | 1.22e-05 | 2 | 122 | 2 | 17175102 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19487679 | ||
| Pubmed | Phenotypic spectrum of epidermolysis bullosa associated with α6β4 integrin mutations. | 1.22e-05 | 2 | 122 | 2 | 23496044 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 30804437 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 2475502 | ||
| Pubmed | Putative human blue-light photoreceptors hCRY1 and hCRY2 are flavoproteins. | 1.22e-05 | 2 | 122 | 2 | 8909283 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 17442820 | ||
| Pubmed | Circadian rhythm of RNA N6-methyladenosine and the role of cryptochrome. | 1.22e-05 | 2 | 122 | 2 | 26239657 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 35657344 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 11677206 | ||
| Pubmed | Skeletal muscle neural progenitor cells exhibit properties of NG2-glia. | 1.22e-05 | 2 | 122 | 2 | 22999866 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 34910522 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22025708 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18514517 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24386234 | ||
| Pubmed | Role of mouse cryptochrome blue-light photoreceptor in circadian photoresponses. | 1.22e-05 | 2 | 122 | 2 | 9822380 | |
| Pubmed | Serine phosphorylation of mCRY1 and mCRY2 by mitogen-activated protein kinase. | 1.22e-05 | 2 | 122 | 2 | 15298678 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12944498 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24278295 | ||
| Pubmed | High-fat diet-induced hyperinsulinemia and tissue-specific insulin resistance in Cry-deficient mice. | 1.22e-05 | 2 | 122 | 2 | 23531614 | |
| Pubmed | Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. | 1.22e-05 | 2 | 122 | 2 | 16061665 | |
| Pubmed | Circadian clock cryptochrome proteins regulate autoimmunity. | 1.22e-05 | 2 | 122 | 2 | 29109286 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 17529886 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22216107 | ||
| Pubmed | Integrin alpha6 maintains the structural integrity of the kidney collecting system. | 1.22e-05 | 2 | 122 | 2 | 28043890 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 28017587 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 2542022 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12429829 | ||
| Pubmed | Nuclear Proteomics Uncovers Diurnal Regulatory Landscapes in Mouse Liver. | 1.22e-05 | 2 | 122 | 2 | 27818260 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15331384 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18974120 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16258729 | ||
| Pubmed | CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome. | 1.22e-05 | 2 | 122 | 2 | 25391456 | |
| Pubmed | The ratio of intracellular CRY proteins determines the clock period length. | 1.22e-05 | 2 | 122 | 2 | 26966073 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24187535 | ||
| Pubmed | HPV16 infection of HaCaTs is dependent on β4 integrin, and α6 integrin processing. | 1.22e-05 | 2 | 122 | 2 | 24418536 | |
| Pubmed | α6β4 Integrin Regulates the Collective Migration of Epithelial Cells. | 1.22e-05 | 2 | 122 | 2 | 27922761 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 29940771 | ||
| Pubmed | The 3'UTR of the α6 integrin message regulates localization of α6β4 integrin heterodimers. | 1.22e-05 | 2 | 122 | 2 | 30922568 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24782829 | ||
| Pubmed | Redox potential: differential roles in dCRY and mCRY1 functions. | 1.22e-05 | 2 | 122 | 2 | 11818067 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 10518585 | ||
| Pubmed | Mammalian Cry1 and Cry2 are essential for maintenance of circadian rhythms. | 1.22e-05 | 2 | 122 | 2 | 10217146 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12696673 | ||
| Pubmed | A role for oxysterol-binding protein-related protein 5 in endosomal cholesterol trafficking. | 1.22e-05 | 2 | 122 | 2 | 21220512 | |
| Pubmed | Analysis of autophosphorylating kinase activities of Arabidopsis and human cryptochromes. | 1.22e-05 | 2 | 122 | 2 | 17073458 | |
| Pubmed | Mammalian cryptochromes impinge on cell cycle progression in a circadian clock-independent manner. | 1.22e-05 | 2 | 122 | 2 | 22033214 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18614689 | ||
| Pubmed | Synchronization of cellular clocks in the suprachiasmatic nucleus. | 1.22e-05 | 2 | 122 | 2 | 14631044 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21388972 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 11687802 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 1976638 | ||
| Pubmed | Further characterization of the phenotype of mCry1/mCry2-deficient mice. | 1.22e-05 | 2 | 122 | 2 | 11587085 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 32291799 | ||
| Pubmed | Suppression of circadian clock protein cryptochrome 2 promotes osteoarthritis. | 1.22e-05 | 2 | 122 | 2 | 32339698 | |
| Pubmed | Alpha 6 beta 4 integrin abnormalities in junctional epidermolysis bullosa with pyloric atresia. | 1.22e-05 | 2 | 122 | 2 | 11251584 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 27763564 | ||
| Pubmed | CRY1 and CRY2 genetic variants in seasonality: A longitudinal and cross-sectional study. | 1.22e-05 | 2 | 122 | 2 | 27267441 | |
| Pubmed | α6β4 integrin, a master regulator of expression of integrins in human keratinocytes. | 1.22e-05 | 2 | 122 | 2 | 22493440 | |
| Pubmed | Developmentally regulated expression of the beta 4 integrin on immature mouse thymocytes. | 1.22e-05 | 2 | 122 | 2 | 1385605 | |
| Pubmed | Altered food-anticipatory activity rhythm in Cryptochrome-deficient mice. | 1.22e-05 | 2 | 122 | 2 | 15893577 | |
| Pubmed | Circadian behavioral rhythms in Cry1/Cry2 double-deficient mice induced by methamphetamine. | 1.22e-05 | 2 | 122 | 2 | 18258761 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 2070796 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 8875079 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15542431 | ||
| Cytoband | 2q37 | 7.79e-05 | 31 | 122 | 3 | 2q37 | |
| Cytoband | 3p25.3 | 2.39e-04 | 45 | 122 | 3 | 3p25.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 3.59e-04 | 226 | 122 | 5 | chr2q37 | |
| Cytoband | 10q24.33 | 4.54e-04 | 12 | 122 | 2 | 10q24.33 | |
| GeneFamily | Olfactory receptors, family 6 | 6.53e-05 | 51 | 77 | 4 | 153 | |
| GeneFamily | UDP glucuronosyltransferases | 3.37e-04 | 32 | 77 | 3 | 363 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-07 | 181 | 119 | 7 | 709e9c7a60d5f98635b99895ce30bb87a9f7376d | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 1.15e-05 | 188 | 119 | 6 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 192 | 119 | 6 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.42e-05 | 195 | 119 | 6 | 31353269591c9eee84872838e91995d4a035da46 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-05 | 198 | 119 | 6 | 1d30a1f73b6d6d838f49751402a29c5ef54aa81f | |
| ToppCell | proximal-Hematologic-Alveolar_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.55e-05 | 198 | 119 | 6 | a5deecd8809bc5b38ffda02143598ad0145e2559 | |
| ToppCell | proximal-Hematologic-Alveolar_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.55e-05 | 198 | 119 | 6 | ec0092ef6207e788e2c20ddf007a2f6f6e351d0b | |
| ToppCell | proximal-3-Hematologic-Alveolar_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.55e-05 | 198 | 119 | 6 | a5daf11bf7fe614be9f4a0fc6a4b37b5dce2f6fc | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.59e-05 | 199 | 119 | 6 | edb68a4f622a494f22fd7b25bc40ae0d58456cdb | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-05 | 199 | 119 | 6 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.59e-05 | 199 | 119 | 6 | d58edc5f74970bb26d844746184e4bae7c494d6b | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-05 | 199 | 119 | 6 | 448dd5a27d57627468c6b8347f1b6b1005aea004 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-05 | 199 | 119 | 6 | 45f9c03d2ed2d98d66086fb0251bd24e30c6f775 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.06e-05 | 155 | 119 | 5 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.46e-05 | 162 | 119 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 166 | 119 | 5 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 166 | 119 | 5 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 179 | 119 | 5 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.22e-04 | 180 | 119 | 5 | 410ea13a9c00cf54b4d47c72404dfe893c086d87 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 180 | 119 | 5 | 8ab16a0b9053bffc07b569a4f9e71749f56dde7e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.22e-04 | 180 | 119 | 5 | 394cd465b88429b70eebb2957480dffcbc51cfe7 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 182 | 119 | 5 | 42e3d32911d5d5cc14d8391623968af594cf2e5f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-04 | 183 | 119 | 5 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.32e-04 | 183 | 119 | 5 | c1297d8eddfc7132e84ceef14f01b6281f9d0f6a | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 186 | 119 | 5 | f0b78c7ee20279970ea8961bf59acb5262f2dce5 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 1.43e-04 | 186 | 119 | 5 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 186 | 119 | 5 | 2b3c814a7dee8286ea113c63dc3de5daf0257d37 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-04 | 186 | 119 | 5 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.46e-04 | 187 | 119 | 5 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | E12.5-Endothelial|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.46e-04 | 187 | 119 | 5 | b8ed57b3c39ffbf750cd08a3e03ec11dae43d00e | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 187 | 119 | 5 | 52ffd4be374e329ac8d321063f061b826d252956 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.50e-04 | 188 | 119 | 5 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 189 | 119 | 5 | 37ce47abd6f96df04d35a4a6189d007bef5ccc94 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 189 | 119 | 5 | b55324cb365a827d071952709bbf0e8ef8c313de | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 189 | 119 | 5 | 62e46d59d3b89d4566b595c704d8b02f1ea9060b | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 189 | 119 | 5 | 25db316f66cee53774bb2b286cc457b37353356c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 189 | 119 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 189 | 119 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 190 | 119 | 5 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 190 | 119 | 5 | d4aefae2d3164db6a9e953c54af0151501e9d1da | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 190 | 119 | 5 | e64b191f928935484e2c993d7f8af0572a617a3a | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-04 | 191 | 119 | 5 | 38fe60a8570f3c6eb8e8f8646f90d505dfd7d647 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.62e-04 | 191 | 119 | 5 | 0e6cd2628a5cebd35e960e4eb3b52ddc9358031c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 191 | 119 | 5 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 191 | 119 | 5 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | Endothelial-A|World / shred on cell class and cell subclass (v4) | 1.65e-04 | 192 | 119 | 5 | 9919cdc0ce833894525dba429f251ea1b094fbd8 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.65e-04 | 192 | 119 | 5 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | Endothelial|World / shred on cell class and cell subclass (v4) | 1.65e-04 | 192 | 119 | 5 | 2b13cca5c4b58628dbbbb356859632dba66d43f9 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 192 | 119 | 5 | 35f7926628a967f85b26371e795a1b93c6f103ab | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-04 | 192 | 119 | 5 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 193 | 119 | 5 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 193 | 119 | 5 | ce5c3ab79900aa6f394c894267340167009c6149 | |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.70e-04 | 193 | 119 | 5 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 1.70e-04 | 193 | 119 | 5 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 193 | 119 | 5 | 643f992dbce639e7d147924d8b8f455fcebf215a | |
| ToppCell | facs-MAT-Fat-3m-Endothelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | b32533afeff1905e188becaa09079e9699722e4b | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | 2ff573ba2c74583ed1cb071a3bbc01bb71117e5f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 193 | 119 | 5 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 193 | 119 | 5 | 634fdd157cd1efeebf6ecc810bc45e138331451a | |
| ToppCell | facs-MAT-Fat-3m-Endothelial-endothelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | e164f6403a8b541ced08a6feec915d2e855036ea | |
| ToppCell | droplet-Lung-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-04 | 193 | 119 | 5 | 95c9c63bddfed1a84393ccd3578cfe65bc0c1c05 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 193 | 119 | 5 | 01c71aa48875b5ad6c50cc810a72862e72f26ad0 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.74e-04 | 194 | 119 | 5 | 3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956 | |
| ToppCell | 15-Airway-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 1.74e-04 | 194 | 119 | 5 | ac0e48b0c09a7f57d30dff321b0c30a4c5e16ad9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 119 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | 15-Airway-Endothelial-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 1.74e-04 | 194 | 119 | 5 | f3851337a2d17f4acef2cd812a766eb0b503748b | |
| ToppCell | Endothelial-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.74e-04 | 194 | 119 | 5 | abea887dd472c1a0d572e690bc8914c1b94712ad | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.74e-04 | 194 | 119 | 5 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | PND28-Endothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-04 | 194 | 119 | 5 | b592c713204db7ae2f34a54f2d03d13834593c57 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 1.74e-04 | 194 | 119 | 5 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-04 | 194 | 119 | 5 | fc3f81b5bdc544a69c355e482f002643e029a7b0 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 119 | 5 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.74e-04 | 194 | 119 | 5 | 53a5e8863d79a052dff0758f389be5ac3883c721 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-04 | 194 | 119 | 5 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-04 | 194 | 119 | 5 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 119 | 5 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.74e-04 | 194 | 119 | 5 | c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.78e-04 | 195 | 119 | 5 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-04 | 195 | 119 | 5 | 65fc50e3818e902028fc4226070fa57609c66b9c | |
| ToppCell | 11.5-Distal-Endothelial|Distal / Age, Tissue, Lineage and Cell class | 1.78e-04 | 195 | 119 | 5 | efdede0f476883ffddd247fa7bc6449e7932613e | |
| ToppCell | 11.5-Distal-Endothelial-Endothelial|Distal / Age, Tissue, Lineage and Cell class | 1.78e-04 | 195 | 119 | 5 | 1e9b52b201ab6c78f536609e2afe1d680c71a6e7 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-04 | 195 | 119 | 5 | 3b79e6bb525b17192ecec9e1227a29c419968144 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.78e-04 | 195 | 119 | 5 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | facs-GAT-Fat-3m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 196 | 119 | 5 | b6cc1f466d45479764080d34b1daeb8243a5a9f3 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 196 | 119 | 5 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature2_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 196 | 119 | 5 | b0288e28a6e6222a9e310eb6fe228c04b618db13 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 196 | 119 | 5 | 2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b | |
| ToppCell | PCW_13-14-Endothelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 196 | 119 | 5 | 7286de29a34e13834cd6347c67a1443897fa4ade | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 196 | 119 | 5 | b826dce5b3daa8eb3d4a530b9564de58d9ce3767 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 196 | 119 | 5 | ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 196 | 119 | 5 | 29ed8b1c4cd730db8632fde6eece404f1883a86d | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 196 | 119 | 5 | c65b8c7ea34a21897c390e6fb42ee8ca41e9c976 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 196 | 119 | 5 | 039044ab28c53391c34d8226fb8cf78549e63ef4 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 196 | 119 | 5 | 481d79bdaec069ad2746a28d39eeee8d3edf7305 | |
| ToppCell | 11.5-Airway-Endothelial-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 1.82e-04 | 196 | 119 | 5 | 509ddea8d6e1d0b832f69490ab8a736af4ca19a8 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 196 | 119 | 5 | 9ed96085f0acce07bf2f8d4cc212cc50e613be0c | |
| ToppCell | PCW_10-12-Endothelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.82e-04 | 196 | 119 | 5 | 2c60dcf9132ee156f25b349e2ac5313709def4f6 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 1.82e-04 | 196 | 119 | 5 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| Drug | naringenin chalcone | 1.35e-06 | 5 | 118 | 3 | ctd:C027329 | |
| Drug | anthrarobin | 1.35e-06 | 5 | 118 | 3 | ctd:C032186 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 2.68e-06 | 6 | 118 | 3 | ctd:C543211 | |
| Drug | alloin | 2.68e-06 | 6 | 118 | 3 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 2.68e-06 | 6 | 118 | 3 | ctd:C107497 | |
| Drug | 2',4'-dihydroxychalcone | 4.68e-06 | 7 | 118 | 3 | ctd:C059354 | |
| Drug | 1,4-dihydroxyanthraquinone | 7.46e-06 | 8 | 118 | 3 | ctd:C034890 | |
| Drug | AC1MRQNQ | 1.11e-05 | 9 | 118 | 3 | CID003522271 | |
| Drug | DHPASiU | 1.11e-05 | 9 | 118 | 3 | CID000197602 | |
| Drug | Chebi:32663 | 1.11e-05 | 9 | 118 | 3 | CID005460873 | |
| Drug | 3-iodophenol | 1.11e-05 | 9 | 118 | 3 | CID000012272 | |
| Drug | AC1L4J7U | 1.11e-05 | 9 | 118 | 3 | CID000186631 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.27e-05 | 28 | 118 | 4 | CID000081261 | |
| Drug | H-Ni | 1.27e-05 | 28 | 118 | 4 | CID000445665 | |
| Drug | 2,6-dihydroxyanthraquinone | 1.59e-05 | 10 | 118 | 3 | ctd:C034889 | |
| Drug | paricalcitol | 1.69e-05 | 30 | 118 | 4 | CID005281104 | |
| Drug | 4-nitrophenyl)imidazole | 2.17e-05 | 11 | 118 | 3 | CID000123155 | |
| Drug | AC1O5XMV | 2.17e-05 | 11 | 118 | 3 | CID006442661 | |
| Drug | Z 338 | 2.66e-05 | 2 | 118 | 2 | ctd:C410959 | |
| Drug | N-OH-DABZ | 2.89e-05 | 12 | 118 | 3 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 2.89e-05 | 12 | 118 | 3 | CID000088735 | |
| Drug | 4-hydroxyestrone | 2.89e-05 | 12 | 118 | 3 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 2.89e-05 | 12 | 118 | 3 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 2.89e-05 | 12 | 118 | 3 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 2.89e-05 | 12 | 118 | 3 | CID000160090 | |
| Drug | 2-hydroxyestrone | 3.74e-05 | 13 | 118 | 3 | ctd:C024980 | |
| Drug | tritanol | 3.74e-05 | 13 | 118 | 3 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 3.74e-05 | 13 | 118 | 3 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 3.74e-05 | 13 | 118 | 3 | CID000000411 | |
| Drug | alizarin | 3.74e-05 | 13 | 118 | 3 | ctd:C010078 | |
| Drug | propranolol glucuronide | 4.74e-05 | 14 | 118 | 3 | CID000119515 | |
| Drug | PCB-61 | 4.74e-05 | 14 | 118 | 3 | CID000036401 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 5.90e-05 | 15 | 118 | 3 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 5.90e-05 | 15 | 118 | 3 | CID000010752 | |
| Drug | bergamottin | 5.90e-05 | 15 | 118 | 3 | ctd:C068337 | |
| Drug | sulforaphane nitrile | 5.90e-05 | 15 | 118 | 3 | CID000543743 | |
| Drug | afloqualone | 5.90e-05 | 15 | 118 | 3 | CID000002040 | |
| Drug | naphthyl sulphate | 5.90e-05 | 15 | 118 | 3 | CID000114775 | |
| Drug | quercetin-3,4'-diglucoside | 7.23e-05 | 16 | 118 | 3 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 7.23e-05 | 16 | 118 | 3 | CID000040003 | |
| Drug | bilirubin-phosphate | 7.23e-05 | 16 | 118 | 3 | CID005497144 | |
| Drug | N-hydroxy-PhIP | 7.24e-05 | 43 | 118 | 4 | CID000104954 | |
| Drug | Un9 | 7.96e-05 | 3 | 118 | 2 | CID006914666 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 8.75e-05 | 17 | 118 | 3 | CID000003573 | |
| Drug | 6-hydroxychrysene | 8.75e-05 | 17 | 118 | 3 | CID000037766 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 1.05e-04 | 18 | 118 | 3 | CID000152226 | |
| Drug | Br 2 | 1.05e-04 | 18 | 118 | 3 | CID003060900 | |
| Drug | SureCN12722713 | 1.05e-04 | 18 | 118 | 3 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 1.05e-04 | 18 | 118 | 3 | CID000036614 | |
| Drug | ApApG | 1.05e-04 | 18 | 118 | 3 | CID003081975 | |
| Drug | C1 11-32 | 1.05e-04 | 18 | 118 | 3 | CID000443077 | |
| Drug | C11131 | 1.05e-04 | 18 | 118 | 3 | CID000443076 | |
| Drug | 1-hydroxypyrene | 1.12e-04 | 48 | 118 | 4 | CID000021387 | |
| Drug | almokalant | 1.24e-04 | 19 | 118 | 3 | CID003033962 | |
| Drug | 9-OH-risperidone | 1.24e-04 | 19 | 118 | 3 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.24e-04 | 19 | 118 | 3 | CID000091433 | |
| Drug | ethoxyresorufin | 1.37e-04 | 95 | 118 | 5 | CID000003294 | |
| Drug | tectochrysin | 1.45e-04 | 20 | 118 | 3 | CID005281954 | |
| Drug | AC1L1OBF | 1.45e-04 | 20 | 118 | 3 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 1.45e-04 | 20 | 118 | 3 | CID000116545 | |
| Drug | entacapone | 1.45e-04 | 20 | 118 | 3 | ctd:C071192 | |
| Drug | sitafloxacin | 1.59e-04 | 4 | 118 | 2 | ctd:C076246 | |
| Drug | 2-vanillin | 1.59e-04 | 4 | 118 | 2 | ctd:C060843 | |
| Drug | hydratropic acid | 1.59e-04 | 4 | 118 | 2 | ctd:C013025 | |
| Drug | diphenylacetic acid | 1.59e-04 | 4 | 118 | 2 | ctd:C037760 | |
| Drug | estriol-16-glucuronide | 1.69e-04 | 21 | 118 | 3 | CID000122281 | |
| Drug | dulcin | 1.69e-04 | 21 | 118 | 3 | CID000009013 | |
| Drug | 7-hydroxycoumarin | 1.69e-04 | 21 | 118 | 3 | ctd:C031477 | |
| Drug | Benzamidoxime hydrochloride | 1.69e-04 | 21 | 118 | 3 | CID000069186 | |
| Drug | amonafide | 1.94e-04 | 22 | 118 | 3 | CID000050515 | |
| Drug | plumbagin | 1.94e-04 | 22 | 118 | 3 | ctd:C014758 | |
| Drug | N-methylpiperazine | 1.94e-04 | 22 | 118 | 3 | CID000053167 | |
| Drug | amidoxime | 2.23e-04 | 23 | 118 | 3 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 2.23e-04 | 23 | 118 | 3 | CID000066651 | |
| Drug | phenanthridine | 2.23e-04 | 23 | 118 | 3 | CID000009189 | |
| Drug | morin | 2.34e-04 | 58 | 118 | 4 | ctd:C008548 | |
| Drug | AS-3201 | 2.54e-04 | 24 | 118 | 3 | CID000153948 | |
| Drug | ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxzoleacetate | 2.64e-04 | 5 | 118 | 2 | ctd:C052488 | |
| Drug | isovaleric acid | 2.64e-04 | 5 | 118 | 2 | ctd:C008216 | |
| Drug | biphenylylacetic acid | 2.64e-04 | 5 | 118 | 2 | ctd:C012776 | |
| Drug | 2-naphthylamine | 2.72e-04 | 110 | 118 | 5 | CID000007057 | |
| Drug | 5-MOP | 2.87e-04 | 25 | 118 | 3 | CID000002355 | |
| Drug | Hymecromone | 2.87e-04 | 25 | 118 | 3 | ctd:D006923 | |
| Drug | AzMC | 2.87e-04 | 25 | 118 | 3 | CID000064986 | |
| Drug | N-acetylbenzidine | 2.87e-04 | 25 | 118 | 3 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 2.87e-04 | 25 | 118 | 3 | CID000006796 | |
| Drug | N-phenylmaleimide | 2.87e-04 | 25 | 118 | 3 | CID000013662 | |
| Drug | Thymol | 3.23e-04 | 26 | 118 | 3 | ctd:D013943 | |
| Drug | lamotrigine | 3.48e-04 | 116 | 118 | 5 | CID000003878 | |
| Drug | Scopoletin | 3.62e-04 | 27 | 118 | 3 | ctd:D012603 | |
| Drug | DiMeIQx | 3.62e-04 | 27 | 118 | 3 | CID000104739 | |
| Drug | licochalcone A | 3.62e-04 | 27 | 118 | 3 | ctd:C070840 | |
| Drug | diflunisal | 3.62e-04 | 27 | 118 | 3 | CID000003059 | |
| Drug | alpha-naphthoflavone | 3.77e-04 | 118 | 118 | 5 | CID000011790 | |
| Drug | 3-phenylpropionic acid | 3.94e-04 | 6 | 118 | 2 | ctd:C035253 | |
| Drug | Indoprofen | 3.94e-04 | 6 | 118 | 2 | ctd:D007216 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.00e-04 | 184 | 118 | 6 | 2321_DN | |
| Drug | CARMINE | 4.04e-04 | 28 | 118 | 3 | CID000014749 | |
| Drug | erucin | 4.04e-04 | 28 | 118 | 3 | CID000078160 | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; HL60; HT_HG-U133A | 4.12e-04 | 185 | 118 | 6 | 2927_DN | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 5.15e-07 | 5 | 111 | 3 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 5.15e-07 | 5 | 111 | 3 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 5.15e-07 | 5 | 111 | 3 | EFO_0801853 | |
| Disease | X-21339 measurement | 1.79e-06 | 7 | 111 | 3 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.86e-06 | 8 | 111 | 3 | EFO_0800766 | |
| Disease | X-11442 measurement | 4.28e-06 | 9 | 111 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 4.28e-06 | 9 | 111 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 4.28e-06 | 9 | 111 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.28e-06 | 9 | 111 | 3 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.28e-06 | 9 | 111 | 3 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.28e-06 | 9 | 111 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 4.28e-06 | 9 | 111 | 3 | EFO_0800698 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 4.28e-06 | 9 | 111 | 3 | EFO_0004570, GO_0009410 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.28e-06 | 9 | 111 | 3 | EFO_0020691 | |
| Disease | X-21448 measurement | 6.10e-06 | 10 | 111 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 6.10e-06 | 10 | 111 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 6.10e-06 | 10 | 111 | 3 | EFO_0800867 | |
| Disease | bilirubin measurement, response to tenofovir | 6.10e-06 | 10 | 111 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21796 measurement | 8.36e-06 | 11 | 111 | 3 | EFO_0800825 | |
| Disease | pregnenetriol sulfate measurement | 8.36e-06 | 11 | 111 | 3 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 8.36e-06 | 11 | 111 | 3 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 8.36e-06 | 11 | 111 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 8.36e-06 | 11 | 111 | 3 | EFO_0800972 | |
| Disease | aldosterone measurement | 8.36e-06 | 11 | 111 | 3 | EFO_0010219 | |
| Disease | biliverdin measurement | 1.11e-05 | 12 | 111 | 3 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 1.11e-05 | 12 | 111 | 3 | EFO_0800079 | |
| Disease | junctional epidermolysis bullosa with pyloric atresia (is_implicated_in) | 1.40e-05 | 2 | 111 | 2 | DOID:0060733 (is_implicated_in) | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 1.40e-05 | 2 | 111 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | retinol dehydrogenase 16 measurement | 1.44e-05 | 13 | 111 | 3 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 1.44e-05 | 13 | 111 | 3 | EFO_0800587 | |
| Disease | X-21441 measurement | 3.39e-05 | 17 | 111 | 3 | EFO_0800814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 3.39e-05 | 17 | 111 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 4.06e-05 | 18 | 111 | 3 | EFO_0801382 | |
| Disease | blood 4-oxo-retinoic acid measurement | 4.20e-05 | 3 | 111 | 2 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 4.20e-05 | 3 | 111 | 2 | EFO_0800043 | |
| Disease | Epidermolysis bullosa with pyloric atresia | 4.20e-05 | 3 | 111 | 2 | C1856934 | |
| Disease | tissue factor measurement | 6.56e-05 | 21 | 111 | 3 | EFO_0010623 | |
| Disease | urate measurement, spine bone mineral density | 6.88e-05 | 58 | 111 | 4 | EFO_0004531, EFO_0007701 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.58e-04 | 28 | 111 | 3 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 1.76e-04 | 29 | 111 | 3 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.95e-04 | 30 | 111 | 3 | EFO_0600017 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 2.08e-04 | 6 | 111 | 2 | EFO_0800566 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 2.91e-04 | 7 | 111 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 2.91e-04 | 7 | 111 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | vitamin D deficiency | 3.67e-04 | 37 | 111 | 3 | EFO_0003762 | |
| Disease | Congenital disorder of glycosylation | 3.97e-04 | 38 | 111 | 3 | cv:C0282577 | |
| Disease | hepatocyte growth factor-like protein measurement | 3.97e-04 | 38 | 111 | 3 | EFO_0008154 | |
| Disease | Alzheimer disease, fasting blood glucose measurement | 4.96e-04 | 9 | 111 | 2 | EFO_0004465, MONDO_0004975 | |
| Disease | egg allergy measurement | 4.96e-04 | 9 | 111 | 2 | EFO_0007018 | |
| Disease | indoleacetate measurement | 6.19e-04 | 10 | 111 | 2 | EFO_0021015 | |
| Disease | estrogen measurement | 6.19e-04 | 10 | 111 | 2 | EFO_0011007 | |
| Disease | N-acetylphenylalanine measurement | 7.54e-04 | 11 | 111 | 2 | EFO_0800019 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 8.42e-04 | 49 | 111 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | vitamin D measurement, COVID-19 | 8.42e-04 | 49 | 111 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | X-24588 measurement | 1.06e-03 | 13 | 111 | 2 | EFO_0800898 | |
| Disease | response to lithium ion | 1.24e-03 | 56 | 111 | 3 | GO_0010226 | |
| Disease | melanoma | 1.33e-03 | 126 | 111 | 4 | EFO_0000756 | |
| Disease | Rhabdomyosarcoma | 1.43e-03 | 15 | 111 | 2 | C0035412 | |
| Disease | Tremor, Rubral | 1.63e-03 | 16 | 111 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.63e-03 | 16 | 111 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.63e-03 | 16 | 111 | 2 | C0278161 | |
| Disease | Seasonal Affective Disorder | 1.63e-03 | 16 | 111 | 2 | C0085159 | |
| Disease | Abnormal coordination | 1.63e-03 | 16 | 111 | 2 | C0520966 | |
| Disease | Idiopathic pulmonary arterial hypertension | 1.63e-03 | 16 | 111 | 2 | C3203102 | |
| Disease | Ataxia, Truncal | 1.63e-03 | 16 | 111 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 1.63e-03 | 16 | 111 | 2 | C0240991 | |
| Disease | urate measurement | DOCK3 HDAC5 TOP6BL PIGU DNAH1 SLC17A1 TGFBRAP1 CSPG4 HEATR5B EPAS1 | 2.05e-03 | 895 | 111 | 10 | EFO_0004531 |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.34e-03 | 147 | 111 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | physical activity measurement | 2.38e-03 | 245 | 111 | 5 | EFO_0008002 | |
| Disease | urate measurement, bone density | 2.39e-03 | 619 | 111 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 2.46e-03 | 71 | 111 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | free androgen index | 2.96e-03 | 374 | 111 | 6 | EFO_0007005 | |
| Disease | serum metabolite measurement | UGT1A8 UGT1A7 UGT1A9 CCNYL3 C2orf78 SLC17A1 VPS41 ALK PPP6R3 PHLPP2 | 3.03e-03 | 945 | 111 | 10 | EFO_0005653 |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.45e-03 | 80 | 111 | 3 | DOID:6432 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LTTTFYGSAPAQLLP | 86 | Q75L30 | |
| FSNLTAGPYPLIITI | 386 | Q8WWZ7 | |
| LLGPSFESYLLPELT | 826 | Q99814 | |
| LPAFSLTPLEYISNI | 616 | P83436 | |
| RVSGPYFPTLLGLSL | 1381 | Q6UVK1 | |
| YFPTLLGLSLQVLEP | 1386 | Q6UVK1 | |
| PLYPSLSASLVQGTL | 176 | A6NCI8 | |
| SLGLVLPPYSTFYLQ | 636 | Q9NY47 | |
| VLLLLGPPATIFDNY | 851 | O43306 | |
| GLPFLLENPSGYLSR | 246 | Q92685 | |
| INSSPALLPNLTLGY | 81 | P41180 | |
| YGLGLLLTPPLALFL | 51 | Q86XJ0 | |
| AYSAGILLAPPLVLF | 51 | Q8IU99 | |
| DIVYLEPTFPLLLGT | 151 | Q96AZ1 | |
| LTLGQLLTYPLLEFA | 1121 | Q96M86 | |
| TQLPSLPYLSVLSGA | 3656 | Q96M86 | |
| TSPLEYNLPSSLLDF | 1141 | Q9UPW5 | |
| SSALLLLLVPGYFPL | 11 | Q08708 | |
| FYSSLLALPPALETA | 66 | P56750 | |
| LDFLPPGLLLSAYLE | 251 | Q96D70 | |
| LYSTLPALLDSNPFT | 711 | Q5U651 | |
| IFTIRSDPGLTAPLY | 46 | A0A096LPK9 | |
| ELLTLPYLSGQFTTP | 136 | Q14207 | |
| EVLPCLLSPFSLLLY | 631 | Q86TB9 | |
| LLSPFSLLLYHLPSV | 636 | Q86TB9 | |
| SGLLYLAQELPAPSR | 276 | Q16849 | |
| SLVYTLGTPLLNPLI | 266 | Q8NGF6 | |
| ISYLPPSLLSLNDLQ | 686 | A4D1F6 | |
| ARGYSLNLIPPALIS | 41 | Q8N158 | |
| LYPLAKFTAELGLSP | 691 | Q14526 | |
| SGAFTDLTSLPLYLP | 1891 | O60318 | |
| PPLTSLQLSLKYLFA | 426 | Q96EX3 | |
| LEYSLSLLNLPPLEN | 2876 | Q5CZC0 | |
| LPTDPLLLILSFLDY | 16 | Q9UK99 | |
| TPLLPDSLVYQIFLS | 6 | Q969U6 | |
| TLLYASSLFQGSVPP | 186 | O95544 | |
| IFTIRSDPGLTAPLY | 46 | Q8N0Y3 | |
| SYSLLPQSTAPGLFL | 606 | Q9Y5F6 | |
| PLSSLTFLSLLQPFF | 556 | Q6NT32 | |
| SYLLPLLQRLLGQPS | 181 | Q9NUL7 | |
| LGETLPDSTPLGFYL | 1291 | P48681 | |
| LLQDLPAPGFLFYTR | 246 | Q6ZNW5 | |
| PVPANSYLGLLFLTS | 251 | P23229 | |
| GFLTPILPIYLLSQL | 156 | Q8NGQ2 | |
| LRGSLYYLLSALPQP | 256 | Q32M88 | |
| STLLTAFILTGIPYP | 6 | Q8NGC4 | |
| NPTELVPYGLSLRLA | 811 | P16144 | |
| LSAFPVLYLDLAPST | 396 | Q96ES6 | |
| YQSLYPLTLFVPGLL | 191 | Q9H490 | |
| LSLPPGDIYNLSVTA | 691 | Q16827 | |
| LSLLGVNYPLSPGLF | 206 | P0CG20 | |
| LNPPGTLNIYLFCLT | 26 | Q86SP6 | |
| SLGVFSYIGLPLTLI | 671 | O15118 | |
| YSPLSSQPVLGALSL | 231 | P0C7X3 | |
| YLLDSPSLRLDTPIF | 61 | Q96A29 | |
| SLPSSIIIGPFYINT | 796 | Q9P2D7 | |
| LALNPLLLSNILYPG | 2791 | Q3L8U1 | |
| ILALLPPKTYEGSFN | 676 | Q9P2D3 | |
| YALLTLPAEFSSQLP | 1491 | Q9P2D3 | |
| SLLTQLFGPYPSLLE | 1161 | Q8IZD9 | |
| NSLLASPTGLSPYLR | 261 | Q49AN0 | |
| NGLPPSYTIILLFRL | 2571 | Q99715 | |
| QLYGPFLIVVPLSTL | 531 | O14647 | |
| YLPQLTGSSILPALD | 326 | Q00532 | |
| HPLASLPLLGYSLTI | 971 | Q9Y4F1 | |
| YISLLPLGDGLTLAF | 246 | Q86VU5 | |
| ANSLLASPTGLSPYL | 241 | Q16526 | |
| PYVQQTFSLLLPLLG | 621 | Q9NSG2 | |
| SFLLTILLELTYQGP | 11 | Q6UXX5 | |
| GTAAILSFLLRPQYP | 476 | Q9Y4D2 | |
| LAIPELVFYPSLESG | 926 | Q9NYC9 | |
| FSLYTSPSLPNISLG | 361 | Q9UQL6 | |
| VLFPPGIFYSALLSL | 581 | Q92674 | |
| AFLLPILSQIYTDGP | 231 | O15523 | |
| FLPTPDSLLVNLYES | 751 | O95487 | |
| ALGVLSPSYLAPLTR | 86 | A6NKX4 | |
| GGLVLYNLPFPLLLT | 536 | Q5FWE3 | |
| YNLPFPLLLTALAAL | 541 | Q5FWE3 | |
| LYSSLFQPLGISLPV | 111 | Q9HBV1 | |
| YLTPQILLPFSPLTS | 6 | C9J302 | |
| GLSIILPQTELSFYL | 111 | Q96LT7 | |
| GLPTAPGLQYLLFLL | 16 | Q6IFH4 | |
| LAGLLYTVLSPTLNP | 291 | Q8NGR1 | |
| NLLLSGDNELYPLSP | 31 | Q9H0X9 | |
| GNFTIIIISYLDPPL | 41 | Q8NGZ4 | |
| GLLSLLYLPTGFFSL | 621 | Q9BVN2 | |
| DLLPGAPILSLRFSY | 606 | Q8N1F8 | |
| PFYSSDILIASPLGL | 441 | Q68CQ4 | |
| FLSSPTYRALLLQGP | 196 | P49795 | |
| AKLPFTPLSYIQGLS | 166 | Q9UM00 | |
| PPLIVSLASYSLLIF | 191 | Q9NYW6 | |
| SIFLYGPLGLPLILS | 246 | Q8N6T0 | |
| APGRALLYSLSQPLA | 131 | P17542 | |
| LLPAIFGVCLPYLSS | 346 | Q14916 | |
| TGLYLLPLSSTQSPL | 791 | P58107 | |
| LPYATIIPRSDLNGL | 56 | Q9C0A6 | |
| FLNLSVYSLPQLLGP | 326 | O15389 | |
| TIPYLGLLTSQNLPL | 536 | P03915 | |
| YTVLLLPLGTSRQDP | 16 | Q5SSQ6 | |
| GFPTAPGLQYLLFLL | 16 | Q8NGW1 | |
| GVALLYTSIAPLLNP | 271 | A6NF89 | |
| YPRLTSQLFIDLSPL | 791 | Q7RTU9 | |
| LAAASSPALPGVYLL | 106 | Q96BI1 | |
| SPALPGVYLLFASRL | 111 | Q96BI1 | |
| VSFISPLGILYTPAL | 956 | Q9UM73 | |
| YTSLPSLGLEQPLAL | 121 | Q14135 | |
| RELISLYPFLLPTSS | 381 | Q8WUH2 | |
| SLFLLLQYLPPGVIA | 331 | Q8IU68 | |
| SASALYGQPLLLSVP | 596 | Q13107 | |
| SQPSLGLLVRTYPEL | 916 | Q13009 | |
| NVYPVPSLLTFLDLS | 496 | Q6ZVD8 | |
| SVLLPLLLLYNDPFF | 351 | Q9P2C4 | |
| AEGPITALTFLYLPR | 861 | Q9BXP2 | |
| PRQLLTLYNPTGTAL | 51 | O75425 | |
| SRISPPTFYGLNSLI | 211 | Q9HBX9 | |
| LVYFLPSLPADLLSR | 621 | Q9NXF1 | |
| GAQLSTPVLLSVLYP | 781 | Q9BZZ2 | |
| LTPTLSGFLESPLKY | 791 | O43151 | |
| PLSYVPRILLGFSDA | 186 | O60656 | |
| LYSIDKPPFITGLLN | 701 | P49754 | |
| GTYVLQDNSFPLLLP | 91 | O75865 | |
| LAQPTLLYLRGPFSL | 1236 | P78527 | |
| IPRETSPYLANLLLG | 236 | Q8IYT8 | |
| GSYLVPPSLVQLILL | 1336 | Q01118 | |
| YPRLTSQLFIDLSPL | 791 | A6NGW2 | |
| LLPTEISQSLLYRGP | 896 | Q92508 | |
| PLPLELYTSSNFIGL | 161 | Q8TF42 | |
| PLSSPGFSLLFYLVI | 466 | Q5H8A4 | |
| LYSFLLNDSPLNPLL | 106 | Q5H9R7 | |
| PLSYVPRLLLGFSDA | 186 | Q9HAW7 | |
| PLSYVPRILLGFSDA | 186 | Q9HAW9 |